Nivedita Gupta Selected Research

BBV152 COVID-19 vaccine

9/2022	Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study.
12/2021	Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
10/2021	Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.
10/2021	Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine.
1/2021	Antibody responses to the BBV152 vaccine in individuals previously infected with SARS-CoV-2: A pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nivedita Gupta Research Topics

Disease

16	COVID-19 12/2024 - 02/2020
10	Rubella (German Measles) 01/2024 - 12/2018
7	Measles 01/2024 - 01/2021
6	Infections 12/2021 - 01/2019
3	Scrub Typhus (Typhus, Scrub) 01/2023 - 01/2017
3	Human Influenza (Influenza) 01/2023 - 01/2019
3	Dengue (Dengue Fever) 01/2021 - 01/2019
2	Severe Acute Respiratory Syndrome 02/2021 - 02/2020
2	Pneumonia (Pneumonitis) 01/2021 - 01/2021
2	Bacterial Meningitis 01/2021 - 01/2018
2	Acquired Immunodeficiency Syndrome (AIDS) 02/2020 - 03/2006
2	Cross Infection (Nosocomial Infection) 01/2020 - 01/2020
2	Burns 03/2006 - 05/2005
1	Neoplasms (Cancer) 01/2024
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024
1	Carcinoma (Carcinomatosis) 01/2024
1	Virus Diseases (Viral Diseases) 11/2023
1	Mpox (monkeypox) 11/2023
1	Intussusception 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Crimean Hemorrhagic Fever 01/2022
1	Mumps 01/2022
1	Kyasanur Forest Disease 01/2022
1	Anaphylaxis (Anaphylactic Shock) 12/2021
1	Chronic Disease (Chronic Diseases) 12/2021
1	Diphtheria 01/2021
1	Reinfection 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Hepatitis B 11/2020
1	Coronavirus Infections 02/2020
1	Hypotension (Low Blood Pressure) 02/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2020
1	Tuberculosis (Tuberculoses) 02/2020
1	Diabetes Mellitus 02/2020
1	Lung Diseases (Lung Disease) 02/2020
1	Acute Febrile Encephalopathy 01/2020
1	Congenital Rubella Syndrome (Syndrome, Congenital Rubella) 07/2019
1	Asymptomatic Infections 01/2019
1	Thrombocytopenia (Thrombopenia) 11/2018
1	Inappropriate ADH Syndrome (SIADH) 03/2011
1	Hyponatremia 03/2011
1	Hypertension (High Blood Pressure) 03/2011
1	Diarrhea 03/2011
1	Anorexia Nervosa 03/2011
1	Wounds and Injuries (Trauma) 05/2005

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 12/2024 - 01/2018
14	Immunoglobulin G (IgG)IBA 11/2022 - 01/2017
11	AntibodiesIBA 11/2022 - 12/2018
9	Immunoglobulin M (IgM)IBA 01/2023 - 01/2017
5	EnzymesIBA 01/2023 - 03/2006
5	BBV152 COVID-19 vaccineIBA 09/2022 - 01/2021
4	COVID-19 VaccinesIBA 09/2022 - 10/2021
3	AntigensIBA 01/2021 - 01/2019
2	ChAdOx1 nCoV-19IBA 12/2024 - 09/2022
2	ImmunosorbentsIBA 01/2023 - 07/2019
2	Viral RNAIBA 01/2022 - 01/2021
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2024
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 11/2023
1	DNA VaccinesIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2022
1	Indicators and Reagents (Reagents)IBA 08/2022
1	rubella antibodiesIBA 01/2022
1	Rubella VaccineIBA 01/2022
1	aluminum sulfate (alum)IBA 12/2021
1	Toll-Like Receptor 7IBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2021
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 01/2021
1	Viral AntigensIBA 01/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2020
1	Lopinavir FDA Link 02/2020
1	Nucleic AcidsIBA 02/2020
1	Ritonavir (Norvir)FDA Link 02/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Doxycycline (Periostat)FDA LinkGeneric 01/2020
1	Ribavirin (Virazole)FDA LinkGeneric 01/2020
1	Hemagglutinins (Hemagglutinin)IBA 01/2019
1	BilirubinIBA 11/2018
1	LatexIBA 01/2018
1	Conjugate VaccinesIBA 01/2018
1	Hormones (Hormone)IBA 03/2011
1	SaltsIBA 03/2011
1	SodiumIBA 03/2011
1	DiureticsIBA 03/2011
1	IonsIBA 03/2011
1	glyoxylic acid (glyoxylate)IBA 03/2006
1	Glucose (Dextrose)FDA LinkGeneric 05/2005
1	AgarIBA 05/2005

Therapy/Procedure

2	Personal Protective Equipment 10/2022 - 01/2020
1	Therapeutics 02/2020